Gilead Sciences, Inc. (GILD)
147.92
-2.51
(-1.67%)
USD |
NASDAQ |
Oct 13, 16:00
147.80
-0.12
(-0.08%)
After-Hours: 20:00
Gilead Sciences Market Cap : 183.57B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 13, 2026 | 183.57B |
| October 12, 2026 | 186.68B |
| October 09, 2026 | 187.60B |
| October 08, 2026 | 182.55B |
| October 07, 2026 | 182.24B |
| October 06, 2026 | 178.99B |
| October 05, 2026 | 179.49B |
| October 02, 2026 | 179.62B |
| October 01, 2026 | 183.05B |
| September 30, 2026 | 184.97B |
| September 29, 2026 | 187.74B |
| September 28, 2026 | 188.89B |
| September 25, 2026 | 187.30B |
| September 24, 2026 | 185.77B |
| September 23, 2026 | 187.85B |
| September 22, 2026 | 189.46B |
| September 21, 2026 | 186.84B |
| September 18, 2026 | 186.29B |
| September 17, 2026 | 187.25B |
| September 16, 2026 | 183.27B |
| September 15, 2026 | 181.56B |
| September 14, 2026 | 181.69B |
| September 11, 2026 | 178.36B |
| September 10, 2026 | 179.71B |
| September 09, 2026 | 180.75B |
| Date | Value |
|---|---|
| September 08, 2026 | 181.98B |
| September 04, 2026 | 187.38B |
| September 03, 2026 | 187.66B |
| September 02, 2026 | 185.67B |
| September 01, 2026 | 186.05B |
| August 31, 2026 | 181.61B |
| August 28, 2026 | 180.79B |
| August 27, 2026 | 184.74B |
| August 26, 2026 | 183.78B |
| August 25, 2026 | 184.62B |
| August 24, 2026 | 182.10B |
| August 21, 2026 | 181.33B |
| August 20, 2026 | 178.01B |
| August 19, 2026 | 183.17B |
| August 18, 2026 | 178.01B |
| August 17, 2026 | 172.40B |
| August 14, 2026 | 171.70B |
| August 13, 2026 | 171.43B |
| August 12, 2026 | 168.61B |
| August 11, 2026 | 168.49B |
| August 10, 2026 | 165.13B |
| August 07, 2026 | 165.31B |
| August 06, 2026 | 162.40B |
| August 05, 2026 | 163.51B |
| August 04, 2026 | 167.85B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 484.81B |
| Amgen, Inc. | 223.18B |
| Vertex Pharmaceuticals, Inc. | 122.93B |
| Biogen, Inc. | 33.81B |
| Regeneron Pharmaceuticals, Inc. | 77.87B |
Market Cap Related Metrics
| PS Ratio | 6.058 |
| Price to Book Value | 15.52 |
| Price to Free Cash Flow | 14.30 |
| Price | 147.92 |
| Earnings Yield | -1.80% |
| Operating PE Ratio | 15.51 |
| Normalized PE Ratio | 31.13 |